Volastra therapeutics Headquarters & Office Locations

Volastra therapeutics (Private) is headquartered in New York City, New York, United States. Founded in 2019, the company operates across 1 countries with approximately 49 employees worldwide.

Where is Volastra therapeutics's main office?

Volastra therapeutics's main headquarters office is located at 1361 Amsterdam Ave suite 520, New York City, New York 10027. This serves as the company's primary corporate address and is home to its executive leadership team.

Volastra therapeutics regional offices

Beyond its headquarters in New York City, Volastra therapeutics maintains 2 offices across 1 countries. Regional offices span 1 countries.

Volastra therapeutics contact information

The main switchboard for Volastra therapeutics headquarters can be reached at 16463441248. For investor relations, visit volastratx.com/investor-relations.

What does Volastra therapeutics do?

Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient’s CIN status is prognostic for metastasis and that CIN alters metastasis and overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates metastatic disease to develop novel therapeutics.